L. Yalcintepe Et Al. , "Effect of CD38 on the multidrug resistance of human chronic myelogenous leukemia K562 cells to doxorubicin.," Oncology letters , vol.11, no.3, pp.2290-2296, 2016
Yalcintepe, L. Et Al. 2016. Effect of CD38 on the multidrug resistance of human chronic myelogenous leukemia K562 cells to doxorubicin.. Oncology letters , vol.11, no.3 , 2290-2296.
Yalcintepe, L., Halis, E., & Ulku, S., (2016). Effect of CD38 on the multidrug resistance of human chronic myelogenous leukemia K562 cells to doxorubicin.. Oncology letters , vol.11, no.3, 2290-2296.
Yalcintepe, Leman, Emre Halis, And Sibel Ulku. "Effect of CD38 on the multidrug resistance of human chronic myelogenous leukemia K562 cells to doxorubicin.," Oncology letters , vol.11, no.3, 2290-2296, 2016
Yalcintepe, Leman Y. Et Al. "Effect of CD38 on the multidrug resistance of human chronic myelogenous leukemia K562 cells to doxorubicin.." Oncology letters , vol.11, no.3, pp.2290-2296, 2016
Yalcintepe, L. Halis, E. And Ulku, S. (2016) . "Effect of CD38 on the multidrug resistance of human chronic myelogenous leukemia K562 cells to doxorubicin.." Oncology letters , vol.11, no.3, pp.2290-2296.
@article{article, author={Leman YALÇINTEPE GÜNEŞTUTAR Et Al. }, title={Effect of CD38 on the multidrug resistance of human chronic myelogenous leukemia K562 cells to doxorubicin.}, journal={Oncology letters}, year=2016, pages={2290-2296} }